News | RIVM

First vaccinations with Janssen vaccine on Wednesday

The first Janssen vaccines will be administered to mental healthcare workers on Wednesday 21 April.

People with a medical risk between the ages of 18-60 years invited from early May on

Starting in the first week of May, people under 60 who are at risk for medical reasons, i.e.

One in ten tests positive

In the past week, from 14 to 20 April, the reported number of people who tested positive for COVID-19 increased by 5.3%, rising to 53,981 newly reported infections.

Vaccination invitation for people born in 1953, 1954 and 1955 arriving very soon

People born in 1953 and 1954 will receive an invitation for COVID-19 vaccination this week. Starting today, people born in 1953 and 1954 can schedule an appointment.

Support for ‘corona passport’, downward trend in compliance with visitor limits

There seems to be widespread support for introducing a coronavirus passport, also referred to as ‘corona passport’.

Children aged 16-18 years at higher risk for medical reasons will receive first vaccination soon

On 9 April, the Health Council of the Netherlands advised priority COVID-19 vaccination for young people born in 2003, 2004 and 2005 who are in the medical high-risk group.

GPs will invite under-60s with Down's syndrome or morbid obesity for GGD vaccination

People with Down's syndrome and people with morbid obesity born in 1961 or later, who have not yet been vaccinated, will receive a vaccination invitation from their GP.

People born in 1952 invited for COVID-19 vaccination

Starting next week, the first people in the next age group will receive an invitation from RIVM for a COVID-19 vaccination. These people were born in 1952.

Huge leap in vaccinations: nearly 3.8 million doses administered

The vaccination figures published today in the RIVM report and on the Coronavirus Dashboard are higher than in previous weeks.

Sander Koning

Different vaccine very soon available to people under 60, instead of AstraZeneca

Vaccination with AstraZeneca will continue for people aged 60 years and older; the vaccine is still very necessary for that target group.